Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes | Zendy

Neo Tapela | Zendy; Ignace Nzayisenga | Zendy; Roshan V. Sethi | Zendy; Jean Bosco Bigirimana | Zendy; Hamissy Habineza | Zendy; Vedaste Hategekimana | Zendy; Nicholas Mantini | Zendy; Tharcisse Mpunga | Zendy; Lawrence N. Shulman | Zendy; Leslie E. Lehmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes

Author(s) -

Neo Tapela,

Ignace Nzayisenga,

Roshan V. Sethi,

Jean Bosco Bigirimana,

Hamissy Habineza,

Vedaste Hategekimana,

Nicholas Mantini,

Tharcisse Mpunga,

Lawrence N. Shulman,

Leslie E. Lehmann

Publication year - 2016

Publication title -

journal of global oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.002

H-Index - 17

ISSN - 2378-9506

DOI - 10.1200/jgo.2015.001727

Subject(s) - medicine , interquartile range , imatinib , myeloid leukemia , middle income country , public health , family medicine , pediatrics , pathology , economics , demographic economics

The burden of cancer is rising in low- and middle-income countries, yet cancer treatment requires resources that are often not available in these settings. Although management of chronic myeloid leukemia (CML) has been described in low- and middle-income countries, few programs involve patients treated in rural settings. We describe characteristics and early outcomes of patients treated for CML at rural district hospitals in Rwanda.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research